|
1
|
MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines.
|
Cancer Res
|
1997
|
3.38
|
|
2
|
Regulation of Akt/PKB activity, cellular growth, and apoptosis in prostate carcinoma cells by MMAC/PTEN.
|
Cancer Res
|
1999
|
1.95
|
|
3
|
The major mycolic acids of Mycobacterium smegmatis. Characterization of their homologous series.
|
J Biol Chem
|
1979
|
1.92
|
|
4
|
Mycolic acids. A reinvestigation.
|
J Biol Chem
|
1978
|
1.67
|
|
5
|
Differential expression of MMAC/PTEN in glioblastoma multiforme: relationship to localization and prognosis.
|
Cancer Res
|
1999
|
1.66
|
|
6
|
Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis.
|
Cancer Res
|
1998
|
1.52
|
|
7
|
The autocrine loop of TGF-alpha/EGFR and brain tumors.
|
J Neurooncol
|
1997
|
1.40
|
|
8
|
Growth control in cultured 3T3 fibroblasts. Assays of cell proliferation and demonstration of a growth inhibitory activity.
|
J Cell Biol
|
1979
|
1.30
|
|
9
|
Antiangiogenesis treatment for gliomas: transfer of antisense-vascular endothelial growth factor inhibits tumor growth in vivo.
|
Cancer Res
|
1999
|
1.28
|
|
10
|
Inhibition of angiogenesis in human glioblastomas by chromosome 10 induction of thrombospondin-1.
|
Cancer Res
|
1996
|
1.23
|
|
11
|
Differences in transferrin response and numbers of transferrin receptors in rat and human mammary carcinoma lines of different metastatic potentials.
|
J Cell Physiol
|
1993
|
1.23
|
|
12
|
Adenovirus-mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis.
|
Cancer Res
|
1996
|
1.21
|
|
13
|
Elevated levels of M(r) 92,000 type IV collagenase in human brain tumors.
|
Cancer Res
|
1993
|
1.16
|
|
14
|
Analysis of the functional role of chromosome 10 loss in human glioblastomas.
|
Cancer Res
|
1993
|
1.15
|
|
15
|
Cell surface glycoproteins of 13762NF mammary adenocarcinoma clones of differing metastatic potentials.
|
Exp Cell Res
|
1983
|
1.14
|
|
16
|
Growth control in cultured 3T3 fibroblasts II. Molecular properties of a fraction enriched in growth inhibitory activity.
|
J Cell Biol
|
1982
|
1.11
|
|
17
|
Characterization of p53 and p21 functional interactions in glioma cells en route to apoptosis.
|
J Natl Cancer Inst
|
1997
|
1.07
|
|
18
|
Deletion mapping of chromosome 4 in head and neck squamous cell carcinoma.
|
Oncogene
|
1997
|
1.06
|
|
19
|
MMAC1/PTEN inhibits cell growth and induces chemosensitivity to doxorubicin in human bladder cancer cells.
|
Oncogene
|
2000
|
1.06
|
|
20
|
Growth inhibitory effects of interferon-beta but not interferon-alpha on human glioma cells: correlation of receptor binding, 2',5'-oligoadenylate synthetase and protein kinase activity.
|
J Interferon Res
|
1990
|
0.98
|
|
21
|
Tumor necrosis factor modulates epidermal growth factor receptor phosphorylation and kinase activity in human tumor cells. Correlation with cytotoxicity.
|
J Biol Chem
|
1989
|
0.97
|
|
22
|
Modulation of growth and epidermal growth factor receptor activity by retinoic acid in human glioma cells.
|
Cancer Res
|
1989
|
0.97
|
|
23
|
Heat-stress proteins and thermal resistance in rat mammary tumor cells.
|
Radiat Res
|
1983
|
0.96
|
|
24
|
Allelic deletion analyses of MMAC/PTEN and DMBT1 loci in gliomas: relationship to prognostic significance.
|
Clin Cancer Res
|
1998
|
0.92
|
|
25
|
Phenotypic analysis of human glioma cells expressing the MMAC1 tumor suppressor phosphatase.
|
Oncogene
|
1999
|
0.89
|
|
26
|
Role of plasminogen activator and of 92-KDa type IV collagenase in glioblastoma invasion using an in vitro matrigel model.
|
J Neurooncol
|
1994
|
0.86
|
|
27
|
Differential amplification of the TGF-alpha gene in human gliomas.
|
Cancer Commun
|
1990
|
0.85
|
|
28
|
Expression of epidermal growth factor receptor and associated glycoprotein on cultured human brain tumor cells.
|
J Cell Biochem
|
1986
|
0.83
|
|
29
|
Tumor necrosis factor regulates tyrosine phosphorylation on epidermal growth factor receptors in A431 carcinoma cells: evidence for a distinct mechanism.
|
Cell Growth Differ
|
1992
|
0.83
|
|
30
|
Growth control in cultured 3T3 fibroblasts. III. Binding interactions of a growth inhibitory activity with target cells.
|
Exp Cell Res
|
1982
|
0.82
|
|
31
|
Inactivation of MMAC1 in bladder transitional-cell carcinoma cell lines and specimens.
|
Mol Carcinog
|
2000
|
0.82
|
|
32
|
Growth regulatory activities of endothelial extracellular matrix: mediation by transforming growth factor-beta.
|
Exp Cell Res
|
1990
|
0.82
|
|
33
|
Establishment of a new human pancreatic adenocarcinoma cell line, MDAPanc-3.
|
Pancreas
|
1990
|
0.82
|
|
34
|
Primitive neuroectodermal tumor of the median nerve. Case report with cytogenetic analysis.
|
J Neurosurg
|
1996
|
0.81
|
|
35
|
Transforming growth factor-alpha antisense vectors can inhibit glioma cell growth.
|
J Neurooncol
|
1999
|
0.81
|
|
36
|
Autocrine growth stimulation by transforming growth factor-alpha in human non-small cell lung cancer.
|
Surg Oncol
|
1992
|
0.81
|
|
37
|
Growth inhibitory effect of recombinant alpha and beta interferon on human glioma cells.
|
J Neurooncol
|
1987
|
0.80
|
|
38
|
Cell surface properties of spontaneously metastasizing rat mammary adenocarcinoma cell clones.
|
Transplant Proc
|
1984
|
0.80
|
|
39
|
Monoclonal antibodies against cell-surface antigens of the metastatic rat 13762NF mammary adenocarcinoma and their cross-reactivity with human breast carcinomas.
|
Cancer Res
|
1986
|
0.80
|
|
40
|
A novel approach to glioma gene therapy: down-regulation of the vascular endothelial growth factor in glioma cells using ribozymes.
|
Int J Oncol
|
1998
|
0.79
|
|
41
|
Characterization of interleukin-2-initiated versus OKT3-initiated human tumor-infiltrating lymphocytes from glioblastoma multiforme: growth characteristics, cytolytic activity, and cell phenotype.
|
Cancer Immunol Immunother
|
1991
|
0.78
|
|
42
|
Purification and partial characterization of a tumour-metastasis-associated high-Mr glycoprotein from rat 13762NF mammary adenocarcinoma cells.
|
Biochem J
|
1987
|
0.78
|
|
43
|
Suppression by retinoic acid of epidermal growth factor receptor autophosphorylation and glycosylation in cultured human head and neck squamous carcinoma cells.
|
J Natl Cancer Inst Monogr
|
1992
|
0.77
|
|
44
|
The modulation of astrocytic differentiation in cells derived from a medulloblastoma surgical specimen.
|
J Neurooncol
|
1989
|
0.77
|
|
45
|
In vitro cytolysis of primitive neuroectodermal tumors of the posterior fossa (medulloblastoma) by lymphokine-activated killer cells.
|
J Neurosurg
|
1988
|
0.76
|
|
46
|
Suppression of transformed phenotype and tumorigenicity after transfer of chromosome 4 into U251 human glioma cells.
|
Genes Chromosomes Cancer
|
1997
|
0.76
|
|
47
|
Identification of a novel gene product, RIG, that is down-regulated in human glioblastoma.
|
Oncogene
|
1997
|
0.76
|
|
48
|
Head and neck squamous cell carcinoma cell lines as a model system for the study of oncogene expression during tumor progression and metastasis.
|
Prog Clin Biol Res
|
1986
|
0.75
|
|
49
|
Altered expression of glycosaminoglycans in metastatic 13762NF rat mamma adenocarcinoma cells.
|
Biochemistry
|
1987
|
0.75
|
|
50
|
Heat transient related changes in stress-protein synthesis.
|
Radiat Res
|
1985
|
0.75
|
|
51
|
Differentially expressed gene products in glioblastoma cells suppressed for tumorigenicity.
|
J Neurovirol
|
1998
|
0.75
|
|
52
|
Development and characterization of a syngeneic monoclonal antibody to a rat mammary tumor metastasis-associated mucin-like cell-surface antigen (gp580).
|
Int J Cancer
|
1988
|
0.75
|